Supply Chain

A new ophthalmology device developed by researchers at Nicolaus Copernicus University in Poland and Universidad de Murcia in Spain produces high quality images for examining the whole eye, the Optical Society of America reports. Here are six insights:

Stericycle Expert Solutions assessed five years of recall trends data finding that software is often the top cause of medical device recalls.

Zacks Investment Research believes Valeant Pharmaceuticals will post $2.17 billion in sales for the current financial quarter, Stock News Times reports.

Stock market analysts anticipate Allergan will report full-year earnings of $4.73 per share Feb. 14, according to the Frisco Fastball.  

Valeant will pay down $200 million of its senior secured term loans via cash on hand.

McKesson is closing its Delran, N.J. distribution plant at the end of March and laying off the plant's 102 employees, the Philadelphia Inquirer reports.

Valeant Pharmaceuticals took another hit after Goldman Sachs issued a 'sell' rating and an $18 price target Jan. 24, Schaeffer's reports.

The medical device industry had reason to celebrate after Congress suspended the medical device tax for two years through its stopgap spending measure to reopen the government, STAT reports.

Cowen, a notable Wall Street bank, thinks Amazon will leverage Alexa voice assistance technology in the healthcare space, according to a Business Insider report.

The FDA granted IlluminOss Medical de novo clearance for its IlluminOss Bone Stabilization System.